CIFR
Cipher Mining Inc.
There isn't enough reported data to score CIFR yet.
NEWT
NewtekOne, Inc.
NEWT's fundamentals are mixed: revenue grew only 1.5%, but earnings per share fell 16%. At 5.5x earnings, it's trading below its usual 7.2x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
CIFR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CIFR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIFR.
NEWT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
NEWT's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NEWT.
CIFR PE Valuation
CIFR has no meaningful PE right now: it lost money over the past year.
NEWT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.2x | $10.44 | — |
| Cheap | 5.5x | $10.25 | -1.8% |
| Current | 5.6x | $10.44 | — |
| Fair | 7.1x | $13.41 | +28% |
| Expensive | 10x | $19.07 | +83% |
Historical ranges are pointers, not guarantees.
NEWT's PE is in its cheap range at 5.5x. On analysts' estimates for next year's earnings, today's price would be 5.2x.
CIFR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
CIFR has the edge over NEWT on the outlook, with more favorable earnings and revenue expectations.
NEWT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NEWT's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
CIFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.06 | -$2.86 |
| Q2 2026 | -$2.85 | -$2.40 |
| Q1 2026 | -$2.32 | -$1.94 |
| Q4 2025 | -$2.15 | -$2.01 |
| Q3 2025 | -$0.20 | -$0.07 |
| Q2 2025 | -$0.45 | -850% |
| Q1 2025 | -$0.38 | -733% |
| Q4 2024 | -$0.14 | -$0.04 |
CIFR lost $3.06 per share over the past year, and its loss has widened in each of the last four quarters.
NEWT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.02 | +7.3% |
| Q3 2026 | $1.88 | -16% |
| Q2 2026 | $2.21 | +9.4% |
| Q1 2026 | $2.26 | +17% |
| Q4 2025 | $2.18 | +11% |
| Q3 2025 | $2.24 | +32% |
| Q2 2025 | $2.02 | +24% |
| Q1 2025 | $1.93 | +32% |
| Q4 2024 | $1.96 | +27% |
NEWT has the edge over CIFR on earnings quality, reporting a profit while its opponent remains loss making.
CIFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.7M | -63% |
| Q2 2026 | $24.8M | -43% |
| Q1 2026 | $34.8M | -29% |
| Q4 2025 | $59.7M | +41% |
| Q3 2025 | $71.7M | +198% |
| Q2 2025 | $43.6M | +18% |
| Q1 2025 | $49M | +1.7% |
| Q4 2024 | $42.2M | -2.8% |
CIFR's revenue has slid since its 2025 peak: $27M last quarter, down 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -269% | -217 points |
| Q2 2026 | -316% | -212 points |
| Q1 2026 | -329% | -251 points |
| Q4 2025 | -503% | -544 points |
| Q3 2025 | -52% | +327 points |
| Q2 2025 | -104% | -60 points |
| Q1 2025 | -78% | -175 points |
| Q4 2024 | 40% | +4 points |
CIFR's operating margin was −269% last quarter, down 217 points from the same quarter a year ago.
NEWT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.8M | -4.2% |
| Q2 2026 | $75.1M | +7% |
| Q1 2026 | $71M | +7% |
| Q4 2025 | $73.3M | -2.7% |
| Q3 2025 | $74.9M | +19% |
| Q2 2025 | $70.2M | +15% |
| Q1 2025 | $66.3M | +14% |
| Q4 2024 | $75.4M | +42% |
NEWT has the edge over CIFR on sales, with more consistent year-over-year improvement.
CIFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7B | -$1.4B |
| Q2 2026 | -$653.8M | -$566.3M |
| Q1 2026 | -$462.5M | -$390.7M |
| Q4 2025 | -$280.3M | -$204.2M |
| Q3 2025 | -$256.2M | -$173.1M |
| Q2 2025 | -$87.5M | -$54.3M |
| Q1 2025 | -$71.8M | -$37.3M |
| Q4 2024 | -$76.1M | +$38M |
CIFR's free cash flow was −$3.1B over the past year, against −$492M the year before. Free cash flow isn't a meaningful measure for financial services companies like CIFR.
NEWT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$152.4M | +$14.9M |
| Q2 2026 | -$163.3M | +$36.6M |
| Q1 2026 | -$257.5M | -$196.8M |
| Q4 2025 | -$151.4M | -$59.8M |
| Q3 2025 | -$167.3M | -$141.4M |
| Q2 2025 | -$199.9M | -7108% |
| Q1 2025 | -$60.7M | -$22M |
| Q4 2024 | -$91.7M | -$39M |
NEWT has the edge over CIFR on cash flow, with more consistent year-over-year improvement.
CIFR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.4% | +30.3M shares |
| 1 year | +12% | +46.5M shares |
| 3 years | +75% | +188M shares |
| 5 years | +102% | +222M shares |
CIFR has 440M diluted shares, up 12% from a year ago, despite $151M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7M |
| Q2 2026 | $45.2M |
| Q1 2026 | $3.8M |
| Q4 2025 | $82.3M |
| Q3 2025 | $3M |
| Q2 2025 | $3.2M |
| Q1 2025 | $1.1M |
| Q4 2024 | $16.9M |
CIFR spent $151M buying back its own shares over the past year, about six times what it spent the year before.
NEWT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +51K shares |
| 1 year | +10% | +2.7M shares |
| 3 years | +16% | +4M shares |
NEWT has the edge over CIFR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $167,000 |
| Q3 2025 | — |
CIFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q1 2025 | 125.4x | High |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | -0.7x | Net Cash |
| Q2 2024 | -1.2x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
| Q2 2023 | -0.1x | Net Cash |
CIFR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CIFR.
NEWT Net Leverage
CIFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 7.8 | Oversold |
CIFR's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
NEWT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 2.7 | Oversold |
NEWT's weekly RSI is 36 (neutral) and its Stochastic is 3 (oversold).
CIFR PE vs Financial Services Sector
| Metric | CIFR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
CIFR has no meaningful PE right now: it lost money over the past year.
NEWT PE vs Financial Services Sector
| Metric | NEWT | Sector median | Relative |
|---|---|---|---|
| PE | 5.6x | 13x | 57% below |
| PE % | 19 | 63 | 44 pts below |
NEWT is trading at 5.5x earnings, a 57% discount to the Financial Services sector's median of 13x.
CIFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 33% below |
| 20 week MA | $15.5 | 54% below |
| 50 week MA | $17.0 | 58% below |
| 100 week MA | $12.2 | 41% below |
| 200 week MA | $7.86 | 9% below |
CIFR is in a downtrend: it's below all five of its weekly moving averages, and 9% below its 200-week average.
NEWT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 4.7% below |
| 20 week MA | $12.4 | 16% below |
| 50 week MA | $12.6 | 17% below |
| 100 week MA | $12.1 | 14% below |
| 200 week MA | $13.0 | 19% below |
NEWT is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CIFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $9.95 | +0.3% |
| 2021 | $9.95 | $5.21 | -48% |
| 2022 | $5.21 | $0.54 | -90% |
| 2023 | $0.54 | $4.13 | +665% |
| 2024 | $4.13 | $4.86 | +18% |
| 2025 | $4.86 | $15.2 | +213% |
| 2026 YTD | $15.2 | $7.15 | -53% |
CIFR's yearly returns have swung widely, from +665% in 2023 to −90% in 2022. It's down 53% so far in 2026.
NEWT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $18.2 | -20% |
| 2021 | $18.2 | $27.9 | +54% |
| 2022 | $27.9 | $16.7 | -40% |
| 2023 | $16.7 | $13.8 | -17% |
| 2024 | $13.8 | $13.0 | -5.7% |
| 2025 | $13.0 | $11.5 | -12% |
| 2026 YTD | $11.5 | $10.4 | -9.1% |
NEWT has the edge over CIFR on returns for 2026, with the stronger performance.